CHEK1 and pachyonychia congenita: In our recent report, using the TRAMP NEPC mouse model, we demonstrated that CHK1 inhibition by SRA737 potently suppressed tumor growth, metastasis, and recurrence as a single agent, demonstrating its potential for treating advanced PC.